Previous research in mouse models has shown that a reduction in PU.1 levels represents a situation where there is a progressive block in differentiation and the development of disease that is similar to MPN, even with a propensity to develop AML [3]. This evidence concerns the gene SPI1 and acute myeloid leukemia.